|
Marché Fermé -
Nasdaq
22:00:00 08/05/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
560,11 USD
|
-2,11 %
|
|
-1,30 %
|
-17,21 %
|
|
06/05 |
IDEXX Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
| | |
05/05 |
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Corporate Earnings Rush
| | |
05/05 |
IDEXX Laboratories Q1 Comparable Earnings, Revenue Rise
| | |
05/05 |
IDEXX Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
05/05 |
IDEXX raises annual forecasts on strong pet diagnostics demand
| | |
05/05 |
IDEXX Laboratories Q1 Comparable Earnings, Revenue Rise
| | |
05/05 |
Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 Comparable EPS $3.30, vs. FactSet Est of $3.39
| | |
05/05 |
Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q1 Revenue $1.14B, vs. FactSet Est of $1.12B
| | |
05/05 |
IDEXX Laboratories : Earnings snapshot Q1 2026
| | |
05/05 |
Idexx: Q1 Earnings Snapshot
| | |
05/05 |
IDEXX Laboratories Announces First Quarter Results
| | |
05/05 |
Idexx Laboratories, Inc. Raises Earnings Guidance for the Full Year 2026
| | |
05/05 |
Diagnostics, Vet Visits, Giving Pets a Voice: Jay Mazelsky & Jay Price
| | |
04/05 |
Weekly Earnings Calendar: Palantir, AMD, AXA and Engie in the Spotlight
| | |
04/05 |
Weekly Earnings Calendar: Palantir, AMD, AXA and Engie in the Spotlight
| | |
15/04 |
IDEXX verkündet die Verfügbarkeit des Cancer Dx Tests zur Früherkennung von Lymphomen bei Hunden in Deutschland
| | |
13/04 |
ImmuCell Corporation Announces Board Changes
| | |
08/04 |
IDEXX Laboratories to Release 2026 First Quarter Financial Results
| | |
01/04 |
Idexx Laboratories' Cancer Dx Panel for Canine Lymphoma Early Detection Available in the UK
| | |
01/04 |
Idexx Laboratories, Inc. Announces Uk Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma
| | |
01/04 |
IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma
| | |
26/03 |
IDEXX Laboratories, Inc. Announces Departure of Nimrata Hunt as Executive Vice President, Global Strategy and Commercial, Effective April 13, 2026
| | |
18/03 |
Immucell Corporation Announces Changes to Its Board, Effective April 1, 2026
| | |
02/03 |
IDEXX Laboratories : Raymond James Institutional Investors Conference Presentation
| | |
24/02 |
DENTSPLY SIRONA Inc. Announces Board Changes
| |
Aucun résultat pour cette recherche
Sélectionnez votre édition Toutes les informations financières adaptées au niveau national
Zonebourse is also available in this country: United States.
Switch edition
Rester sur l'édition actuelle
|